Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pristinamycin vs Amoxicillin in Acute Community Acquired Pneumonia
NCT02332577Phase 4Terminated
- Sponsor
- Sanofi
- Start
- Apr 2015
- Primary completion
- Feb 2023
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 4, randomised, double-blind trial of pristinamycin in community acquired pneumonia (CAP) (2 arms), sponsored by Sanofi. Primary endpoint: Percentage of patients cured established from the clinical course and pulmonary radiological course. Started Apr 2015; status: terminated.
02
Drugs
pristinamycin
03
Conditions
community acquired pneumonia (CAP)
Beyond the preview
Go deeper on NCT02332577.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02332577.